P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORAL IRREVERSIBLE MENIN INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA, DIFFUSE LARGE B-CELL LYMPHOMA, AND MULTIPLE MYELOMA

Detaylı Bibliyografya
Asıl Yazarlar:	F. Ravandi-Kashani, A. Kishtagari, H. Carraway, G. Schiller, E. Curran, B. Yadav, A. Cacovean, S. Morris, T. Butler, J. Lancet
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Wiley 2022-06-01
Seri Bilgileri:	HemaSphere
Online Erişim:	http://journals.lww.com/10.1097/01.HS9.0000845236.32931.83

Internet